Peter G Savas - Net Worth and Insider Trading

Peter G Savas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter G Savas owns 2 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , and Alseres Pharmaceuticals Inc (ALSE) .

Click here to see the complete history of Peter G Savas’s form 4 insider trades.

Insider Ownership Summary of Peter G Savas

Ticker	Comapny	Transaction Date	Type of Owner
EYPT	EyePoint Pharmaceuticals Inc	2015-12-03	director
ALSE	Alseres Pharmaceuticals Inc	2009-01-14	director & Chief Executive Officer

Peter G Savas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter G Savas Ownership Network

Ownership Network List of Peter G Savas

No Data

Ownership Network Relation of Peter G Savas

Peter G Savas Owned Company Details

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

Peter G Savas is the director of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , Chief Medical Officer Dario A. Paggiarino , and director & President and CEO Nancy Lurker .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, Peter G Savas made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 3,944,057 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 209 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 581,765 shares, with a net purchase of 581,556 shares. During the past 18 months, 4,194,936 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 3,944,057 shares were bought by its insiders, resulting in a net sale of 250,879 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

Peter G Savas Mailing Address

Above is the net worth, insider trading, and ownership report for Peter G Savas. You might contact Peter G Savas via mailing address: 110 Hartwell Avenue, Lexington Ma 02173.

Discussions on Peter G Savas

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.